CD4 and psoriasis: For example, in the imiquimod (IMQ)-induced psoriasis model, enhanced features of psoriatic inflammation are associated not only with increased expression of STAT3, NF-kB, IFN-γ and TNF-α in CD4+ T cells but also activation of lymphocyte-specific protein tyrosine kinase (Lck) [45].